外泌體研究產品的全球市場

預計到 2030 年，外泌體研究產品的全球市場將達到 13 億美元

2024年，全球外泌體研究產品市場規模估計為4.123億美元，預計到2030年將達到13億美元，在2024-2030年的分析期內，複合年成長率為20.6%。套件和試劑是本報告分析的細分市場之一，預計其複合年成長率為22.2%，到分析期結束時市場規模將達到6.978億美元。設備細分市場在分析期間內的複合年成長率估計為20.0%。

美國市場規模估計為 1.202 億美元，中國市場預計複合年成長率為 19.8%

美國外泌體研究產品市場規模預估2024年達到1.202億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到1.933億美元，在2024-2030年的分析期間內，複合年成長率為19.8%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為18.3%和16.9%。在歐洲，預計德國市場的複合年成長率約為13.7%。

全球外泌體研究產品市場－主要趨勢與促進因素摘要

什麼是外泌體研究產品？為什麼它們很重要？

外泌體研究產品，包括分離試劑套件、精製試劑和表徵工具，對於外泌體的研究至關重要。外泌體是一種在細胞間通訊中發揮關鍵作用並與多種生物過程相關的小型細胞外囊泡。外泌體含有來自母細胞的蛋白質、RNA、DNA 和脂質，是許多疾病的寶貴生物標記物，包括癌症、神經退化性疾病和心血管疾病。由於外泌體能夠攜帶複雜的生物訊息，因此被廣泛用於診斷、治療和藥物傳遞應用的研究。例如，在腫瘤學中，外泌體為了解腫瘤行為提供了寶貴的見解，並提供了一種監測疾病進展和治療反應的非侵入性方法。由於其作為生物標記的潛力，外泌體研究產品在需要可靠的外泌體分離、精製和分析工具的研究人員中需求量很大。

外泌體研究在再生醫學和免疫療法中也發揮重要作用，因為外泌體可以作為治療載體，將藥物或遺傳物質遞送至目標細胞。基於外泌體的藥物遞送系統因其能夠實現標靶治療且副作用極小而備受關注，尤其是在個人化醫療領域。隨著外泌體應用的不斷擴展，高品質、可靠的研究產品對於推進藥物開發和診斷領域的探索至關重要。學術機構、生技公司和製藥公司不斷增加的資金支持外泌體研究的興趣日益濃厚，使得外泌體研究成為醫學領域中一個快速發展的領域。

科技進步如何促進外泌體研究？

技術進步極大地改變了外泌體的研究，使得這些囊泡的分離、表徵和分析更有效率和準確。外泌體研究的關鍵挑戰之一是準確且可重複地分離外泌體，因為它們體積小且通常以低濃度存在於體液中。超速離心、親和性和捕獲和微流體分離技術的最新創新簡化了該流程，使研究人員能夠獲得高純度的外泌體樣本。這些進步不僅提高了研究質量，而且還為分子分析和治療開發等下游應用提供了更可靠的數據。此外，次世代定序(NGS) 和蛋白質組學的發展提高了解剖外泌體內容物的能力，使研究人員能夠識別用於早期檢測疾病的特定生物標記。

此外，結合人工智慧 (AI) 和機器學習 (ML) 的高通量篩檢技術正在實現對大型外泌體資料集的快速分析。這些工具將有助於發現新的生物標記和開發基於外泌體的診斷測試，從而加速精準醫療的進步。流式細胞技術、奈米粒子追蹤分析 (NTA) 和電子顯微鏡的進步也顯著改善了外泌體的表徵，使研究人員能夠以前所未有的精度分析顆粒大小、濃度和分子組成。這些技術突破的結合正在擴展外泌體研究產品的功能，使科學家能夠充分發揮外泌體在診斷、治療和藥物傳輸方面的潛力。

外泌體研究的新應用為何不斷出現？

外泌體的多功能性使其應用領域從診斷擴展到藥物遞送，甚至疫苗開發。在診斷領域，外泌體已被證明是多種疾病（包括癌症、神經退化性疾病和心血管疾病）的寶貴非侵入性生物標記。由於外泌體可以從血液和尿液等易於獲取的體液中獲取，它們代表了傳統切片檢查的一種有希望的替代方案，可以即時監測病情進展和治療反應。液態切片的這些潛在應用促使製藥公司和研究機構投資外泌體研究產品，希望開發出能夠改善疾病早期檢測的高效、非侵入性診斷測試。

製藥業也在探索將外泌體用作藥物遞送載體，因為它們具有天然的生物相容性，並且能夠穿過血腦障壁等生物屏障。這項特性使外泌體特別適用於在治療神經系統疾病時將藥物送到大腦等難以到達的部位。此外，基於外泌體的治療方法在再生醫學中也備受關注，它們透過向目標細胞遞送生長因子來促進組織修復和創傷治療。疫苗開發也是一個新興領域，其中外泌體正在被測試作為抗原載體在調節免疫反應中的作用。外泌體在多個醫學領域的不斷擴展應用推動了對外泌體專用研究產品的需求，這些產品支持外泌體的分離、修飾和功能分析，以用於治療和診斷目的。

是什麼推動了全球外泌體研究產品市場的成長？

外泌體研究產品市場的成長受到多種因素的驅動，這些因素源於技術創新、外泌體應用範圍的不斷擴大以及對生物醫學研究的投資不斷增加。外泌體分離和表徵工具的技術進步顯著提高了外泌體研究的準確性和效率，使其能夠用於生物標記發現和治療遞送等敏感應用。隨著外泌體的診斷和治療用途不斷擴大，製藥和生物技術公司正在大力投資開發基於外泌體的產品，特別是用於癌症診斷、神經退化性疾病和再生療法。這些因素推動了對外泌體分離、分析和改造的高品質研究產品的需求。此外，個人化醫療的興起和對非侵入性診斷工具的需求是市場成長的主要驅動力，因為外泌體為疾病監測和藥物遞送提供了一種微創選擇。公共和私營部門的資金投入不斷增加也加速了市場的發展，因為醫療機構意識到外泌體研究在解決尚未滿足的醫療需求方面的潛力。人們對開發基於外泌體的療法以及利用外泌體進行疫苗遞送的興趣日益濃厚，進一步推動了對專用研究產品的需求。綜合起來，這些因素使外泌體研究成為生命科學的關鍵領域，並支持外泌體分離套件、表徵工具和分析技術市場的持續成長。

部分

組件（套件/試劑、設備、服務）、應用（肺癌、乳癌、前列腺癌、結腸癌、其他應用）、最終用途（學術/研究機構、製藥/生物技術公司、醫院/臨床實驗室）

受訪公司範例

• AMS Biotechnology Ltd.
• Bio-Techne
• Lonza Group AG
• Miltenyi Biotech
• Nanosomix
• Norgen Biotek Corp.
• NX Pharmagen
• Qiagen NV
• System Biosciences（SBI）
• Thermo Fisher Scientific Inc.

目錄

第1章調查方法

第2章執行摘要

• 市場概覽
• 主要企業
• 市場趨勢和促進因素
• 全球市場展望

第3章市場分析

• 美國
• 加拿大
• 日本
• 中國
• 歐洲
• 法國
• 德國
• 義大利
• 英國
• 其他歐洲國家
• 亞太地區
• 其他地區

第4章 競賽

Global Exosome Research Products Market to Reach US$1.3 Billion by 2030

The global market for Exosome Research Products estimated at US$412.3 Million in the year 2024, is expected to reach US$1.3 Billion by 2030, growing at a CAGR of 20.6% over the analysis period 2024-2030. Kits & Reagents, one of the segments analyzed in the report, is expected to record a 22.2% CAGR and reach US$697.8 Million by the end of the analysis period. Growth in the Instruments segment is estimated at 20.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$120.2 Million While China is Forecast to Grow at 19.8% CAGR

The Exosome Research Products market in the U.S. is estimated at US$120.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$193.3 Million by the year 2030 trailing a CAGR of 19.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 18.3% and 16.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.7% CAGR.

Global Exosome Research Products Market - Key Trends & Drivers Summarized

What Are Exosome Research Products and Why Are They Important?

Exosome research products, including isolation kits, purification reagents, and characterization tools, are essential in studying exosomes-small extracellular vesicles that play a critical role in cell-to-cell communication and are linked to a variety of biological processes. Exosomes contain proteins, RNA, DNA, and lipids from their parent cells, making them valuable biomarkers for numerous diseases, including cancer, neurodegenerative disorders, and cardiovascular diseases. With their ability to carry complex biological information, exosomes are used extensively in research for diagnostics, therapeutics, and drug delivery applications. For instance, in oncology, exosomes provide valuable insights into tumor behavior and offer a non-invasive approach to monitoring disease progression and response to treatments. Their potential as biomarkers has led to an increasing demand for exosome research products, as researchers seek reliable tools for exosome isolation, purification, and analysis.

Exosome research is also critical in regenerative medicine and immunotherapy, as exosomes can serve as carriers for therapeutic agents, delivering drugs or genetic material to targeted cells. The use of exosome-based drug delivery systems is gaining traction, especially in personalized medicine, where they enable targeted treatment with minimal side effects. As exosome applications expand, high-quality, reliable research products are crucial for advancing discoveries in drug development and diagnostics. The growing interest in exosome research is supported by increased funding from academic institutions, biotechnology firms, and pharmaceutical companies, making exosome research products a rapidly evolving field in medical science.

How Are Technological Advancements Enhancing Exosome Research?

Technological advancements have significantly transformed exosome research, making the isolation, characterization, and analysis of these vesicles more efficient and precise. One of the critical challenges in exosome research is the accurate and reproducible isolation of exosomes, as they are small and often found in low concentrations in biological fluids. Recent innovations in isolation techniques, such as ultracentrifugation, immunoaffinity capture, and microfluidics, have streamlined the process, enabling researchers to obtain high-purity exosome samples. These advancements not only improve the quality of research but also allow for more reliable data in downstream applications like molecular profiling and therapeutic development. Additionally, developments in next-generation sequencing (NGS) and proteomics have enhanced the ability to analyze exosomal content in detail, enabling researchers to identify specific biomarkers for early disease detection.

Furthermore, high-throughput screening technologies, combined with artificial intelligence (AI) and machine learning (ML), are enabling rapid analysis of large exosome datasets. These tools facilitate the discovery of novel biomarkers and the development of exosome-based diagnostic tests, accelerating progress in precision medicine. Advancements in flow cytometry, nanoparticle tracking analysis (NTA), and electron microscopy have also significantly improved exosome characterization, allowing researchers to analyze particle size, concentration, and molecular composition with unprecedented accuracy. Together, these technological breakthroughs are expanding the capabilities of exosome research products, allowing scientists to unlock the full potential of exosomes in diagnostics, therapeutics, and drug delivery.

Why Are New Applications for Exosome Research Emerging?

The versatility of exosomes is driving their adoption in an increasing number of applications, from diagnostics to drug delivery and even vaccine development. In diagnostics, exosomes are proving to be valuable non-invasive biomarkers for a variety of conditions, including cancer, neurodegenerative diseases, and cardiovascular disorders. Since exosomes can be obtained from easily accessible bodily fluids, such as blood and urine, they offer a promising alternative to traditional biopsies, allowing for real-time monitoring of disease progression and treatment response. This potential for liquid biopsy applications is encouraging pharmaceutical companies and research institutions to invest in exosome research products, hoping to develop efficient, non-invasive diagnostic tests that improve early disease detection.

The pharmaceutical industry is also exploring the use of exosomes as drug delivery vehicles due to their natural biocompatibility and ability to cross biological barriers, such as the blood-brain barrier. This property makes exosomes particularly valuable for delivering drugs to hard-to-reach areas, such as the brain, in treating neurological diseases. Additionally, exosome-based therapies are gaining attention in regenerative medicine, where they are used to promote tissue repair and wound healing by delivering growth factors to target cells. Vaccine development is yet another emerging area, with exosomes being tested as carriers for antigens in immune response modulation. These expanding applications across multiple medical fields highlight the growing demand for specialized exosome research products that support the isolation, modification, and functional analysis of exosomes for therapeutic and diagnostic purposes.

What’s Driving the Growth of the Global Exosome Research Products Market?

The growth in the exosome research products market is driven by several factors, rooted in technological innovation, the expanding scope of exosome applications, and increasing investment in biomedical research. Technological advancements in exosome isolation and characterization tools have significantly improved the precision and efficiency of exosome research, enabling their use in highly sensitive applications such as biomarker discovery and therapeutic delivery. As diagnostic and therapeutic applications for exosomes continue to expand, pharmaceutical and biotech companies are heavily investing in the development of exosome-based products, particularly for cancer diagnostics, neurodegenerative diseases, and regenerative therapies. These factors are propelling demand for high-quality research products that facilitate the isolation, analysis, and modification of exosomes. Additionally, the rise of personalized medicine and the demand for non-invasive diagnostic tools are major drivers of market growth, as exosomes offer a minimally invasive option for disease monitoring and drug delivery. Increased funding from both public and private sectors is also accelerating the market, as institutions recognize the potential of exosome research in addressing unmet medical needs. The development of exosome-based therapeutics and the growing interest in leveraging exosomes for vaccine delivery further contribute to the demand for specialized research products. Collectively, these factors are positioning exosome research as a critical field within life sciences, supporting sustained growth in the market for exosome isolation kits, characterization tools, and analytical technologies.

SCOPE OF STUDY:

The report analyzes the Exosome Research Products market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Kits & Reagents, Instruments, Services); Application (Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Other Applications); End-Use (Academic & Research Institutes, Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

• AMS Biotechnology Ltd.
• Bio-Techne
• Lonza Group AG
• Miltenyi Biotech
• Nanosomix
• Norgen Biotek Corp.
• NX Pharmagen
• Qiagen N.V.
• System Biosciences (SBI)
• Thermo Fisher Scientific Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Global Economic Update
  • Exosome Research Products - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Interest in Exosome-Based Diagnostics and Therapeutics Drives Growth in Exosome Research Products and Technologies
  • Increased Focus on Cancer Research Expands Demand for Exosome Products as Biomarkers for Early Detection and Monitoring
  • Advances in Exosome Isolation and Purification Technologies Improve Accuracy, Supporting Growth in Research Applications
  • Growing Investment in Regenerative Medicine Fuels Demand for Exosome Products in Cell Therapy and Tissue Engineering
  • Expansion of Precision Medicine Drives Demand for Exosome Products in Personalized Drug Delivery Solutions
  • Increased Adoption of Exosome-Based Liquid Biopsies Expands Applications in Non-Invasive Cancer Screening
  • Technological Advancements in Exosome Characterization Tools Enhance Research Capabilities for Drug Development
  • Rising Demand for Exosome Products in Neurological Disorders Supports Research in Brain and CNS Therapeutics
  • Growing Interest in Exosome-Based Vaccine Development Fuels Demand for High-Quality Exosome Research Products
  • Increasing Research Funding for Extracellular Vesicle (EV) Studies Drives Demand for Exosome Isolation Kits and Reagents
  • Expansion of Exosome Research in Cardiovascular and Autoimmune Diseases Supports Development of Targeted Therapies
  • Advances in Microfluidic and Nanotechnology-Based Exosome Isolation Methods Enhance Precision and Efficiency
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for Exosome Research Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 2: World 6-Year Perspective for Exosome Research Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
  • TABLE 3: World Recent Past, Current & Future Analysis for Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 4: World 6-Year Perspective for Kits & Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 6: World 6-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 7: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 8: World 6-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 9: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 10: World 6-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals & Clinical Testing Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 12: World 6-Year Perspective for Hospitals & Clinical Testing Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 13: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 14: World 6-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 15: World Recent Past, Current & Future Analysis for Lung Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 16: World 6-Year Perspective for Lung Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Breast Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 18: World 6-Year Perspective for Breast Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 19: World Recent Past, Current & Future Analysis for Prostate Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 20: World 6-Year Perspective for Prostate Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 21: World Recent Past, Current & Future Analysis for Colorectal Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 22: World 6-Year Perspective for Colorectal Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 24: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 25: World Exosome Research Products Market Analysis of Annual Sales in US$ for Years 2015 through 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Exosome Research Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 26: USA Recent Past, Current & Future Analysis for Exosome Research Products by Component - Kits & Reagents, Instruments and Services - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 27: USA 6-Year Perspective for Exosome Research Products by Component - Percentage Breakdown of Value Sales for Kits & Reagents, Instruments and Services for the Years 2025 & 2030
  • TABLE 28: USA Recent Past, Current & Future Analysis for Exosome Research Products by End-Use - Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 29: USA 6-Year Perspective for Exosome Research Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes for the Years 2025 & 2030
  • TABLE 30: USA Recent Past, Current & Future Analysis for Exosome Research Products by Application - Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 31: USA 6-Year Perspective for Exosome Research Products by Application - Percentage Breakdown of Value Sales for Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications for the Years 2025 & 2030
• CANADA
  • TABLE 32: Canada Recent Past, Current & Future Analysis for Exosome Research Products by Component - Kits & Reagents, Instruments and Services - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 33: Canada 6-Year Perspective for Exosome Research Products by Component - Percentage Breakdown of Value Sales for Kits & Reagents, Instruments and Services for the Years 2025 & 2030
  • TABLE 34: Canada Recent Past, Current & Future Analysis for Exosome Research Products by End-Use - Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 35: Canada 6-Year Perspective for Exosome Research Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes for the Years 2025 & 2030
  • TABLE 36: Canada Recent Past, Current & Future Analysis for Exosome Research Products by Application - Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 37: Canada 6-Year Perspective for Exosome Research Products by Application - Percentage Breakdown of Value Sales for Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications for the Years 2025 & 2030
• JAPAN
  • Exosome Research Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 38: Japan Recent Past, Current & Future Analysis for Exosome Research Products by Component - Kits & Reagents, Instruments and Services - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 39: Japan 6-Year Perspective for Exosome Research Products by Component - Percentage Breakdown of Value Sales for Kits & Reagents, Instruments and Services for the Years 2025 & 2030
  • TABLE 40: Japan Recent Past, Current & Future Analysis for Exosome Research Products by End-Use - Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 41: Japan 6-Year Perspective for Exosome Research Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes for the Years 2025 & 2030
  • TABLE 42: Japan Recent Past, Current & Future Analysis for Exosome Research Products by Application - Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 43: Japan 6-Year Perspective for Exosome Research Products by Application - Percentage Breakdown of Value Sales for Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications for the Years 2025 & 2030
• CHINA
  • Exosome Research Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 44: China Recent Past, Current & Future Analysis for Exosome Research Products by Component - Kits & Reagents, Instruments and Services - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 45: China 6-Year Perspective for Exosome Research Products by Component - Percentage Breakdown of Value Sales for Kits & Reagents, Instruments and Services for the Years 2025 & 2030
  • TABLE 46: China Recent Past, Current & Future Analysis for Exosome Research Products by End-Use - Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 47: China 6-Year Perspective for Exosome Research Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes for the Years 2025 & 2030
  • TABLE 48: China Recent Past, Current & Future Analysis for Exosome Research Products by Application - Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 49: China 6-Year Perspective for Exosome Research Products by Application - Percentage Breakdown of Value Sales for Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications for the Years 2025 & 2030
• EUROPE
  • Exosome Research Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 50: Europe Recent Past, Current & Future Analysis for Exosome Research Products by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 51: Europe 6-Year Perspective for Exosome Research Products by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
  • TABLE 52: Europe Recent Past, Current & Future Analysis for Exosome Research Products by Component - Kits & Reagents, Instruments and Services - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 53: Europe 6-Year Perspective for Exosome Research Products by Component - Percentage Breakdown of Value Sales for Kits & Reagents, Instruments and Services for the Years 2025 & 2030
  • TABLE 54: Europe Recent Past, Current & Future Analysis for Exosome Research Products by End-Use - Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 55: Europe 6-Year Perspective for Exosome Research Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes for the Years 2025 & 2030
  • TABLE 56: Europe Recent Past, Current & Future Analysis for Exosome Research Products by Application - Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Europe 6-Year Perspective for Exosome Research Products by Application - Percentage Breakdown of Value Sales for Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications for the Years 2025 & 2030
• FRANCE
  • Exosome Research Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 58: France Recent Past, Current & Future Analysis for Exosome Research Products by Component - Kits & Reagents, Instruments and Services - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 59: France 6-Year Perspective for Exosome Research Products by Component - Percentage Breakdown of Value Sales for Kits & Reagents, Instruments and Services for the Years 2025 & 2030
  • TABLE 60: France Recent Past, Current & Future Analysis for Exosome Research Products by End-Use - Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 61: France 6-Year Perspective for Exosome Research Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes for the Years 2025 & 2030
  • TABLE 62: France Recent Past, Current & Future Analysis for Exosome Research Products by Application - Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 63: France 6-Year Perspective for Exosome Research Products by Application - Percentage Breakdown of Value Sales for Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications for the Years 2025 & 2030
• GERMANY
  • Exosome Research Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 64: Germany Recent Past, Current & Future Analysis for Exosome Research Products by Component - Kits & Reagents, Instruments and Services - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 65: Germany 6-Year Perspective for Exosome Research Products by Component - Percentage Breakdown of Value Sales for Kits & Reagents, Instruments and Services for the Years 2025 & 2030
  • TABLE 66: Germany Recent Past, Current & Future Analysis for Exosome Research Products by End-Use - Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 67: Germany 6-Year Perspective for Exosome Research Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes for the Years 2025 & 2030
  • TABLE 68: Germany Recent Past, Current & Future Analysis for Exosome Research Products by Application - Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Germany 6-Year Perspective for Exosome Research Products by Application - Percentage Breakdown of Value Sales for Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications for the Years 2025 & 2030
• ITALY
  • TABLE 70: Italy Recent Past, Current & Future Analysis for Exosome Research Products by Component - Kits & Reagents, Instruments and Services - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 71: Italy 6-Year Perspective for Exosome Research Products by Component - Percentage Breakdown of Value Sales for Kits & Reagents, Instruments and Services for the Years 2025 & 2030
  • TABLE 72: Italy Recent Past, Current & Future Analysis for Exosome Research Products by End-Use - Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 73: Italy 6-Year Perspective for Exosome Research Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes for the Years 2025 & 2030
  • TABLE 74: Italy Recent Past, Current & Future Analysis for Exosome Research Products by Application - Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Italy 6-Year Perspective for Exosome Research Products by Application - Percentage Breakdown of Value Sales for Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications for the Years 2025 & 2030
• UNITED KINGDOM
  • Exosome Research Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 76: UK Recent Past, Current & Future Analysis for Exosome Research Products by Component - Kits & Reagents, Instruments and Services - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 77: UK 6-Year Perspective for Exosome Research Products by Component - Percentage Breakdown of Value Sales for Kits & Reagents, Instruments and Services for the Years 2025 & 2030
  • TABLE 78: UK Recent Past, Current & Future Analysis for Exosome Research Products by End-Use - Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 79: UK 6-Year Perspective for Exosome Research Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes for the Years 2025 & 2030
  • TABLE 80: UK Recent Past, Current & Future Analysis for Exosome Research Products by Application - Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 81: UK 6-Year Perspective for Exosome Research Products by Application - Percentage Breakdown of Value Sales for Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications for the Years 2025 & 2030
• REST OF EUROPE
  • TABLE 82: Rest of Europe Recent Past, Current & Future Analysis for Exosome Research Products by Component - Kits & Reagents, Instruments and Services - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 83: Rest of Europe 6-Year Perspective for Exosome Research Products by Component - Percentage Breakdown of Value Sales for Kits & Reagents, Instruments and Services for the Years 2025 & 2030
  • TABLE 84: Rest of Europe Recent Past, Current & Future Analysis for Exosome Research Products by End-Use - Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 85: Rest of Europe 6-Year Perspective for Exosome Research Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes for the Years 2025 & 2030
  • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Exosome Research Products by Application - Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Rest of Europe 6-Year Perspective for Exosome Research Products by Application - Percentage Breakdown of Value Sales for Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications for the Years 2025 & 2030
• ASIA-PACIFIC
  • Exosome Research Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 88: Asia-Pacific Recent Past, Current & Future Analysis for Exosome Research Products by Component - Kits & Reagents, Instruments and Services - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 89: Asia-Pacific 6-Year Perspective for Exosome Research Products by Component - Percentage Breakdown of Value Sales for Kits & Reagents, Instruments and Services for the Years 2025 & 2030
  • TABLE 90: Asia-Pacific Recent Past, Current & Future Analysis for Exosome Research Products by End-Use - Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 91: Asia-Pacific 6-Year Perspective for Exosome Research Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes for the Years 2025 & 2030
  • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Exosome Research Products by Application - Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Asia-Pacific 6-Year Perspective for Exosome Research Products by Application - Percentage Breakdown of Value Sales for Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications for the Years 2025 & 2030
• REST OF WORLD
  • TABLE 94: Rest of World Recent Past, Current & Future Analysis for Exosome Research Products by Component - Kits & Reagents, Instruments and Services - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 95: Rest of World 6-Year Perspective for Exosome Research Products by Component - Percentage Breakdown of Value Sales for Kits & Reagents, Instruments and Services for the Years 2025 & 2030
  • TABLE 96: Rest of World Recent Past, Current & Future Analysis for Exosome Research Products by End-Use - Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 97: Rest of World 6-Year Perspective for Exosome Research Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes for the Years 2025 & 2030
  • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Exosome Research Products by Application - Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Rest of World 6-Year Perspective for Exosome Research Products by Application - Percentage Breakdown of Value Sales for Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications for the Years 2025 & 2030

IV. COMPETITION